As we approach the 2026 flu season, there's a pressing concern that vaccination rates remain worryingly low, especially when compared to the devastating 2025 season. The statistics are stark: over 1700 lives lost to influenza in 2025, the highest death toll this century and the most recorded cases since 1991.
Despite these alarming figures, influenza notifications in 2026 are currently below previous years, which could lead to a false sense of security. Dr Marsha Somi, Acting Deputy Director-General for the Australian Centre for Disease Control, emphasizes the need for vigilance, particularly regarding vaccination coverage.
Vaccination Rates and Age Groups
Vaccination rates for those aged 65 and over are encouragingly above 60%, but the rates drop significantly for other age groups, ranging from 13% to 37%. This disparity highlights a critical gap in protection, especially considering the potential for serious illness and hospitalization across all age groups.
The Nasal Influenza Vaccine: A Game-Changer?
Professor Kristine Macartney, Director of the Australian National Centre for Immunisation Research and Surveillance, introduces a promising development: the nasal influenza vaccine, now available for children aged 2 to 18. This vaccine, which has been used successfully in countries like the US, Canada, and the UK for decades, offers a needle-free option and has shown effectiveness in reducing hospitalizations by 50%.
The nasal vaccine's arrival in Australia is timely, as it aims to address the decline in immunization rates. With a simple administration process, involving a gentle squirt of liquid into each nostril, it could be a more appealing option for children and their families.
Flu Complacency: A Growing Concern
Professor Macartney raises an important point about the casual attitude many people have towards influenza. Influenza is not just a common cold; it can lead to severe illness, hospitalization, and even death, affecting people of all ages, even those who are otherwise healthy. The complications are significant and can impact anyone.
Strains and Severity: The Influenza Challenge
Professor Patrick Reading, Director of the WHO Collaborating Centre for Reference and Research on Influenza, highlights the complexity of influenza, with its various strains (A and B viruses) and unpredictable severity. While we can anticipate an increase in cases as winter approaches, predicting which strain will dominate is a waiting game.
The good news is that the H1N1 and H3N2 components of the current vaccine in Australia have been updated to better match the circulating viruses expected during our winter. This underscores the importance of vaccination in reducing the risk of hospitalization.
Conclusion: A Call to Action
As we navigate the 2026 flu season, it's crucial to remember the devastating impact of influenza and the importance of vaccination. With the introduction of the nasal vaccine, we have a new tool to combat this potentially deadly virus. It's time to dispel the casual attitude towards influenza and recognize the very real threat it poses to our health and well-being.
